A cut‐off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2265|82|4|598-603

ISSN： 0300-0664

Source： CLINICAL ENDOCRINOLOGY, Vol.82, Iss.4, 2015-04, pp. : 598-603

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Determination of a New Cut-Off Value for the Urinary BTAtrak to Optimize the Detection of Recurrences in the Follow-Up of Patients with Superficial Bladder Carcinoma

By  

Current Urology, Vol. 1, Iss. 1, 2007-09 ,pp. : 42-47

Karger

Access to resources Recommend Favorite

Medullary Thyroid Carcinoma

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1998-09 ,pp. : 334-337

Karger

Access to resources Recommend Favorite

Metastatic medullary thyroid carcinoma to the breast in a patient with combined medullary and papillary carcinoma of thyroid—A case report

By  

DIAGNOSTIC CYTOPATHOLOGY, Vol. 43, Iss. 4, 2015-04 ,pp. : 343-348

John Wiley & Sons Inc

Access to resources Recommend Favorite

Integration of a postoperative calcitonin measurement into an anatomical staging system improves initial risk stratification in medullary thyroid cancer

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 6, 2015-12 ,pp. : 938-942

John Wiley & Sons Inc

Access to resources Recommend Favorite

No calcitonin change in a person taking dulaglutide diagnosed with pre‐existing medullary thyroid cancer

By  

DIABETIC MEDICINE, Vol. 35, Iss. 3, 2018-03 ,pp. : 381-385

John Wiley & Sons Inc

Access to resources Recommend Favorite